Today, the processing of tissue samples by molecular pathology is an integral part of complex tumor diagnostics in order to determine the optimal therapy for our tumor patients. Approximately 50-60 % of tumor tissue samples taken in hospitals should be subjected to molecular analysis in order to determine the genetic alterations relevant for therapy. The determination of genetic alterations is absolutely necessary in order to determine the correct form of treatment for the individual tumour, to prevent unwanted side effects and to prepare the basis of modern precision medicine.
The appropriate method today is called Next Generation Sequencing. This is carried out at the Institute of Pathology of Virchow Laboratories under quality control. The internationally recognized criteria and ring test controls are fulfilled.
RELATED INFORMATIONS
Virchow Laboratories Group Ltd.
Office 1632, 14th floor, No.2 Building
Guangshun South Road 16,
Chaoyang District,
Beijing / China
Virchow Laboratories Group Ltd.
Office B, 15th Floor,
Cameron Plaza,
23-25A Cameron Road, TsimShaTsui,
Kowloon, Hong Kong
© Virchow Laboratories Group 魏尔啸实验室集团有限公司
Virchow Laboratories -
Institute of Pathology
Shanghai East Hospital Tongji University
Sino-German Joint Laboratory
Shanghai East Hospital South Campus
Yuntai Road 1800,
Shanghai / China
OUR LOCATIONS
Lead-in
Main Tasks
Who we are
Pathological Diagnostics
Molecular Analyses
Quality Management
Pathology-Clinic Interdisciplinarity
Contact